World Journal of Surgical Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2026-01-09 ms2000001789660809 来自北京

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;非小细胞肺癌
经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂

38 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2024-11-03 1ddcd3c8m75(暂无匿称) 来自上海

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的

119 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2025-03-01 ms8000000358388514 来自山东省

大家外审专家接审稿的快吗？

92 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2025-03-13 ms7000002033137470 来自广东省

各位大佬可以推荐一下能投综述的水刊么？毕业急需

95 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2023-07-11 shademei 来自河北省

偏重的研究方向：临床研究;胃肠肿瘤;临床
经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元

229 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2023-04-14 赵荒唐来自江苏省

偏重的研究方向：肿瘤生信
经验分享：纯生信投稿接受吗？加了一小点基础实验

216 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2021-12-10 lihaining123

1 Reviewer report received 29 Nov 21
投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？

289 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2022-12-07 摩西摩西来自福建省

1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点

200 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2023-01-23 ms7000000473732286 来自浙江省

请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事

227 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2296558, encodeId=95b722965582b, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;非小细胞肺癌 经验分享：真的非常慎投，三个大修，编辑直接给拒稿了。不是多中心研究还说价值不大，我要是多中心还发你们杂志社么，要是多中心我早往上面发了😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Jan 09 11:35:13 CST 2026, time=2026-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234899, encodeId=eb632234899d3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投了一篇小瘤种的meta分析。一审大修要求14天修回。修回半个月了还没动静，哭屎。忐忑不安的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Sun Nov 03 12:02:51 CST 2024, time=2024-11-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254091, encodeId=cdd3225409133, content=大家外审专家接审稿的快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c859207677, createdName=ms8000000358388514, createdTime=Sat Mar 01 11:46:57 CST 2025, time=2025-03-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2255825, encodeId=09b4225582501, content=各位大佬可以推荐一下能投综述的水刊么？毕业急需, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ccd8512120, createdName=ms7000002033137470, createdTime=Thu Mar 13 01:16:13 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=)]

2022-09-13 xuanzixue02

我的邀请了70个审稿人

197 9 举报

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务